David Fedida

Title: David Fedida: Innovator in Ion Channel Modulation

Introduction

David Fedida is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of medical science, particularly in the area of ion channel modulation. With a total of 3 patents to his name, his work focuses on innovative methods for treating arrhythmias.

Latest Patents

One of David Fedida's latest patents is titled "Ion channel modulating activity I - Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias." This patent outlines methods that can reduce or eliminate early afterdepolarizations and prolongation of the QT interval by administering ion channel modulating compounds to individuals in need. The compounds discussed include cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds. Additionally, the patent describes compositions of these compounds and drugs that may induce early afterdepolarizations, prolongation of the QT interval, and/or Torsades de Pointes.

Career Highlights

David Fedida is associated with Cardiome Pharma Corp., where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic approaches for cardiac conditions.

Collaborations

David has collaborated with notable colleagues, including Gregory N Beatch and Alan M Ezrin, contributing to a dynamic research environment that fosters innovation.

Conclusion

David Fedida's contributions to ion channel modulation represent a significant advancement in the treatment of arrhythmias. His innovative approaches and collaborations continue to shape the future of cardiac therapies.